Omid Cameron Farokhzad

Omid Cameron Farokhzad

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Omid Cameron Farokhzad

Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2007 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
Dan PeerDan Peer
Dan Peer
JKJeffrey M. Karp
Jeffrey M. Karp
SHSeungpyo Hong
Seungpyo Hong
OFOmid C. Farokhzad
Omid C. Farokhzad
RMRimona Margalit
Rimona Margalit
RLRobert Langer
Robert Langer

11 November 2016 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
JSJinjun Shi
Jinjun Shi
PKPhilip W. Kantoff
Philip W. Kantoff
RWRichard Wooster
Richard Wooster
OFOmid C. Farokhzad
Omid C. Farokhzad

1 August 2008 in Molecular Pharmaceutics
Verified
Journal Article
Open access
Frank AlexisFrank Alexis
Frank Alexis
EPEric Pridgen
Eric Pridgen
LMLinda K. Molnar
Linda K. Molnar
OFOmid C. Farokhzad
Omid C. Farokhzad
Nanoparticle (NP) drug delivery systems (5−250 nm) have the potential to improve current disease therapies because of their ability to overcome multiple biological barriers and releasing a therapeutic load in the optimal dosage range. Rapid clearance of circulating nanoparticles during systemic delivery is a critical issue for these systems and has made it necessary to understand the factors affecting particle biodistribution and blood circulation half-life. In this review, we discuss the factors which can influence nanoparticle blood residence time and organ specific accumulation. These factors include interactions with biological barriers and tunable nanoparticle parameters, such as composition, size, core properties, surface modifications (pegylation and surface charge), and finally, targeting ligand functionalization. All these factors have been shown to substantially affect the biodistribution and blood circulation half-life of circulating nanoparticles by reducing the level of nonspecific uptake, delaying opsonization, and increasing the extent of tissue specific accumulation.

27 January 2009 in ACS Nano
Verified
Journal Article
Closed access
OFOmid C. Farokhzad
Omid C. Farokhzad
RLRobert Langer
Robert Langer

8 February 2016 in Chemical Reviews
Verified
Journal Article
Closed access
NKNazila Kamaly
Nazila Kamaly
BYBasit Yameen
Basit Yameen
JWJun Wu
Jun Wu
OFOmid C. Farokhzad
Omid C. Farokhzad

6 June 2017 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
SBShahed Behzadi
Shahed Behzadi
Vahid SerpooshanVahid Serpooshan
Vahid Serpooshan
WTWei Tao
Wei Tao
MHMajd A. Hamaly
Majd A. Hamaly
MAMahmoud Y. Alkawareek
Mahmoud Y. Alkawareek
Morteza MahmoudiMorteza Mahmoudi
Morteza Mahmoudi
Cellular association and trafficking of nanoscale materials enables us to both understand and exploit context-dependent phenomena in various disease states, their pathogenesis, and potential therapeutic approaches.